Histatin–Photodynamic Therapy for Polyene-Resistant Biofilms in a 3D Model
By L.M. Dias, A.C. Pavarina, W.L. Siqueira
Originally at journals.sagepub.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Basic-science findings on histatin–photodynamic therapy against mixed Candida–S. mutans biofilms may eventually inform new adjunctive treatments for refractory oral candidiasis, but the work remains preclinical and offers no immediate changes to practice protocols, materials, or billing.
Key points
- Published in Journal of Dental Research (July 2026, Vol. 105, Issue 8) using a 3-D in-vitro model of polyene-resistant biofilms.
- Tested Histatin 3 and Histatin 5 peptides combined with photodynamic activation; no human or animal dosing data yet.
- Potential future relevance for immunocompromised or xerostomic patients with azole/polyene-resistant thrush, but no marketed product or guideline change expected soon.
- Owners and associates should continue standard antifungals and oral-hygiene measures; monitor peer-reviewed follow-up studies for translational data.
Who should care
Read the original on Journal of Dental Research (JDR)
Full reporting and any paywall content live on journals.sagepub.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Florida dental office remains closed amid patient death investigation
- ·Clinical
Association of toothbrushing, dental flossing, and interdental brushing with stroke risk
- ·Clinical
Clinical accuracy and short-term outcomes of intraoral photogrammetry for complete-arch implant rehabilitation: A retrospective multicentre study on 35 patients
- ·Clinical
Site‐Resolved Gingival Microcirculation and Colour Features in Health and Early Inflammation